ENTRY       D05847                      Drug
NAME        Siplizumab (USAN/INN)
EFFICACY    Immunosuppressant, Anti-CD2 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of auto-immune diseases / immune disorders
TARGET      CD2 [HSA:914] [KO:K06449]
  PATHWAY   hsa04514(914)  Cell adhesion molecules
            hsa04640(914)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CD2 family
                CD2
                 D05847  Siplizumab (USAN/INN)
DBLINKS     CAS: 288392-69-8
            PubChem: 47207508
            NIKKAJI: J2.415.693A
///
